{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:54:57Z","timestamp":1789512897110,"version":"build-2803163510"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2014,5,16]],"date-time":"2014-05-16T00:00:00Z","timestamp":1400198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>\u2003<\/jats:title>\n                  <jats:p>Minimizing post-fracture bone loss is an important aspect of recovery from hip fracture, and determination of factors that affect bone mineral density (BMD) response to treatment after hip fracture may assist in the development of targeted therapeutic interventions. A post hoc analysis of the HORIZON Recurrent Fracture Trial was done to determine the effect of zoledronic acid (ZOL) on total hip (TH) and femoral neck (FN) BMD in subgroups with low-trauma hip fracture. A total of 2127 patients were randomized (1:1) to yearly infusions of ZOL 5\u2009mg (n\u2009=\u20091065) or placebo (n\u2009=\u20091062) within 90 days of operation for low-trauma hip fracture. The 1486 patients with a baseline and at least one post-baseline BMD assessment at TH or FN (ZOL\u2009=\u2009745, placebo\u2009=\u2009741) were included in the analyses. Percentage change from baseline in TH and FN BMD was assessed at months 12 and 24 and compared across subgroups of hip fracture patients. Percentage change from baseline in TH and FN BMD at months 12 and 24 was greater (p\u2009&amp;lt;\u20090.05) in ZOL-treated patients compared with placebo in most subgroups. Treatment-by-subgroup interactions (p\u2009&amp;lt;\u20090.05) indicated that a greater effect on BMD was observed for TH BMD at month 12 in females, in patients in the lower tertile body mass index at baseline (\u226422.6\u2009kg\/m2), and in patients with baseline FN BMD T-score of \u2264 \u20132.5; for FN BMD in patients who received ZOL for &amp;gt;6 weeks post-surgery; and for TH and FN BMD in patients with a history of one or more prior fractures. All interactions were limited to the first 12 months after treatment with none observed for the 24-month comparisons. (Clinical trial registration number NCT00046254.) \u00a9 2014 American Society for Bone and Mineral Research.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/jbmr.2283","type":"journal-article","created":{"date-parts":[[2014,5,16]],"date-time":"2014-05-16T22:42:51Z","timestamp":1400280171000},"page":"2545-2551","source":"Crossref","is-referenced-by-count":9,"title":["Subgroup Variations in Bone Mineral Density Response to Zoledronic Acid After Hip Fracture"],"prefix":"10.1093","volume":"29","author":[{"given":"Jay S","family":"Magaziner","sequence":"first","affiliation":[{"name":"University of MarylandBaltimoreMDUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise L","family":"Orwig","sequence":"additional","affiliation":[{"name":"University of MarylandBaltimoreMDUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W","family":"Lyles","sequence":"additional","affiliation":[{"name":"Duke University Medical Center and the Geriatrics Research Education and Clinical CenterVeterans Affairs Medical CenterDurhamNCUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Nordsletten","sequence":"additional","affiliation":[{"name":"Oslo University HospitalUniversity of OsloOsloNorway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Boonen","sequence":"additional","affiliation":[{"name":"University of LeuvenLeuvenBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D","family":"Adachi","sequence":"additional","affiliation":[{"name":"St. Joseph's HealthcareMcMaster UniversityHamiltonONCanada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Recknor","sequence":"additional","affiliation":[{"name":"United Osteoporosis CentersGainesvilleGAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathleen S","family":"Col\u00f3n-Emeric","sequence":"additional","affiliation":[{"name":"Duke University Medical Center and the Geriatrics Research Education and Clinical CenterVeterans Affairs Medical CenterDurhamNCUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Mesenbrink","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals CorporationEast HanoverNJUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Bucci-Rechtweg","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals CorporationEast HanoverNJUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqin","family":"Su","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals CorporationEast HanoverNJUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasheeda","family":"Johnson","sequence":"additional","affiliation":[{"name":"University of MarylandBaltimoreMDUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl F","family":"Pieper","sequence":"additional","affiliation":[{"name":"Duke University Medical Center and the Geriatrics Research Education and Clinical CenterVeterans Affairs Medical CenterDurhamNCUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,5,16]]},"reference":[{"key":"2024020318460071300_jbmr2283-bib-0001","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00198-003-1515-z","article-title":"Functional outcome and quality of life following hip fracture in elderly women: a prospective controlled study","volume":"15","author":"Boonen","year":"2004","journal-title":"Osteoporos Int."},{"key":"2024020318460071300_jbmr2283-bib-0002","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00198-003-1583-0","article-title":"Consequences of hip fracture on activities of daily life and residential needs","volume":"15","author":"Osnes","year":"2004","journal-title":"Osteoporos Int."},{"key":"2024020318460071300_jbmr2283-bib-0003","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00198-003-1460-x","article-title":"The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies","volume":"14","author":"Colon-Emeric","year":"2003","journal-title":"Osteoporos Int."},{"key":"2024020318460071300_jbmr2283-bib-0004","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s001980050003","article-title":"Loss of bone density and lean body mass after hip fracture","volume":"11","author":"Fox","year":"2000","journal-title":"Osteoporos Int."},{"key":"2024020318460071300_jbmr2283-bib-0005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S8756-3282(97)00082-3","article-title":"Accelerated bone mineral loss following a hip fracture: a prospective longitudinal study","volume":"21","author":"Dirschl","year":"1997","journal-title":"Bone."},{"key":"2024020318460071300_jbmr2283-bib-0006","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1185\/030079903125003062","article-title":"Is bone mineral density predictive of fracture risk reduction","volume":"20","author":"Cefalu","year":"2004","journal-title":"Curr Med Res Opin."},{"key":"2024020318460071300_jbmr2283-bib-0007","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1359\/jbmr.2002.17.12.2222","article-title":"Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment","volume":"17","author":"Miller","year":"2002","journal-title":"J Bone Miner Res."},{"key":"2024020318460071300_jbmr2283-bib-0008","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","article-title":"Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures","volume":"312","author":"Marshall","year":"1996","journal-title":"BMJ."},{"key":"2024020318460071300_jbmr2283-bib-0009","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0169-6009(92)90799-J","article-title":"Preferential osteopenia in women with osteoporotic fractures","volume":"18","author":"Aloia","year":"1992","journal-title":"Bone Miner."},{"key":"2024020318460071300_jbmr2283-bib-0010","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF01625444","article-title":"Preferential low bone mineral density of the femoral neck in patients with a recent fracture of the proximal femur","volume":"1","author":"Chevalley","year":"1991","journal-title":"Osteoporos Int."},{"key":"2024020318460071300_jbmr2283-bib-0011","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/00005131-199509060-00003","article-title":"Correlates of bone mineral density in elderly patients with hip fractures","volume":"9","author":"Dirschl","year":"1995","journal-title":"J Orthop Trauma."},{"key":"2024020318460071300_jbmr2283-bib-0012","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/BF03187468","article-title":"Bone mineral density of the hip measured with dual-energy X-ray absorptiometry in normal elderly women and in patients with hip fracture","volume":"1","author":"Duboeuf","year":"1991","journal-title":"Osteoporos Int."},{"key":"2024020318460071300_jbmr2283-bib-0013","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/8756-3282(93)90243-4","article-title":"Bone mineral mass in hip fracture patients","volume":"14","author":"Karlsson","year":"1993","journal-title":"Bone."},{"key":"2024020318460071300_jbmr2283-bib-0014","first-page":"351","article-title":"Hip mineral density in females with a recent hip fracture","volume":"74","author":"Libanati","year":"1992","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020318460071300_jbmr2283-bib-0015","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/ard.57.6.378","article-title":"Prescribing by general practitioners after an osteoporotic fracture","volume":"57","author":"Torgerson","year":"1998","journal-title":"Ann Rheum Dis."},{"key":"2024020318460071300_jbmr2283-bib-0016","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1532-5415.2000.tb02599.x","article-title":"Expert physician recommendations and current practice patterns for evaluating and treating men with osteoporotic hip fracture","volume":"48","author":"Colon-Emeric","year":"2000","journal-title":"J Am Geriatr Soc."},{"key":"2024020318460071300_jbmr2283-bib-0017","doi-asserted-by":"crossref","first-page":"S25\u2013","DOI":"10.1016\/j.amjmed.2005.12.020","article-title":"Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both","volume":"119","author":"Bonnick","year":"2006","journal-title":"Am J Med."},{"key":"2024020318460071300_jbmr2283-bib-0018","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s00198-008-0604-4","article-title":"Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday","volume":"19","author":"Curtis","year":"2008","journal-title":"Osteoporos Int."},{"key":"2024020318460071300_jbmr2283-bib-0019","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa011807","article-title":"Intravenous zoledronic acid in postmenopausal women with low bone mineral density","volume":"346","author":"Reid","year":"2002","journal-title":"N Engl J Med."},{"key":"2024020318460071300_jbmr2283-bib-0020","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic acid and clinical fractures and mortality after hip fracture","volume":"357","author":"Lyles","year":"2007","journal-title":"N Engl J Med."},{"key":"2024020318460071300_jbmr2283-bib-0021","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1210\/jc.2008-2765","article-title":"Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density","volume":"94","author":"Eastell","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020318460071300_jbmr2283-bib-0022","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1185\/030079904125003683","article-title":"The HORIZON Recurrent Fracture Trial: design of a clinical trial in the prevention of subsequent fractures after low trauma hip fracture repair","volume":"20","author":"Colon-Emeric","year":"2004","journal-title":"Curr Med Res Opin."},{"key":"2024020318460071300_jbmr2283-bib-0023","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s001980050093","article-title":"Updated data on proximal femur bone mineral levels of US adults","volume":"8","author":"Looker","year":"1998","journal-title":"Osteoporos Int."},{"key":"2024020318460071300_jbmr2283-bib-0024","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s001980170087","article-title":"Standardization of bone mineral density at femoral neck, trochanter and Ward's triangle","volume":"12","author":"Lu","year":"2001","journal-title":"Osteoporos Int."},{"key":"2024020318460071300_jbmr2283-bib-0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol\u2014a new facility for the measurement of health-related quality of life","volume":"16","author":"The EuroQol Group","year":"1990","journal-title":"Health Policy."},{"key":"2024020318460071300_jbmr2283-bib-0026","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","article-title":"EuroQol: the current state of play","volume":"37","author":"Brooks","year":"1996","journal-title":"Health Policy."},{"key":"2024020318460071300_jbmr2283-bib-0027","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1532-5415.1975.tb00927.x","article-title":"A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients","volume":"23","author":"Pfeiffer","year":"1975","journal-title":"J Am Geriatr Soc."},{"key":"2024020318460071300_jbmr2283-bib-0028","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrrheum.2009.260","article-title":"Osteoporosis: impact on health and economics","volume":"6","author":"Harvey","year":"2010","journal-title":"Nat Rev Rheumatol."},{"key":"2024020318460071300_jbmr2283-bib-0029","author":"Kinsella"},{"key":"2024020318460071300_jbmr2283-bib-0030","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/jbmr.1863","article-title":"Trends in hip fracture rates in Canada: an age-period-cohort analysis","volume":"28","author":"Jean","year":"2013","journal-title":"J Bone Miner Res."},{"key":"2024020318460071300_jbmr2283-bib-0031","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/ageing\/afs177","article-title":"Trends in hip fracture incidence and mortality in Chinese population from Hong Kong 2001-09","volume":"42","author":"Chau","year":"2013","journal-title":"Age Ageing."},{"key":"2024020318460071300_jbmr2283-bib-0032","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1007\/s00198-011-1888-3","article-title":"Hip fracture incidence is decreasing in the high incidence area of Oslo","volume":"23","author":"Stoen","year":"2012","journal-title":"Norway. Osteoporos Int."},{"key":"2024020318460071300_jbmr2283-bib-0033","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00198-011-1601-6","article-title":"Secular trends in the incidence of hip and other osteoporotic fractures","volume":"22","author":"Cooper","year":"2011","journal-title":"Osteoporos Int."},{"key":"2024020318460071300_jbmr2283-bib-0034","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3949\/ccjm.72.11.1033","article-title":"What is a \u2018failure\u2019 of bisphosphonate therapy for osteoporosis","volume":"72","author":"Carey","year":"2005","journal-title":"Cleve Clin J Med."},{"key":"2024020318460071300_jbmr2283-bib-0035","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.2106\/JBJS.G.00864","article-title":"Low incidence of anti-osteoporosis treatment after hip fracture","volume":"90","author":"Rabenda","year":"2008","journal-title":"J Bone Joint Surg Am."},{"key":"2024020318460071300_jbmr2283-bib-0036","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00198-004-1652-z","article-title":"The impact of compliance with osteoporosis therapy on fracture rates in actual practice","volume":"15","author":"Caro","year":"2004","journal-title":"Osteoporos Int."},{"key":"2024020318460071300_jbmr2283-bib-0037","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.maturitas.2004.02.005","article-title":"Compliance with drug therapies for the treatment and prevention of osteoporosis","volume":"48","author":"McCombs","year":"2004","journal-title":"Maturitas."},{"key":"2024020318460071300_jbmr2283-bib-0038","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1001\/archinte.163.18.2165","article-title":"Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation","volume":"163","author":"Feldstein","year":"2003","journal-title":"Arch Intern Med."},{"key":"2024020318460071300_jbmr2283-bib-0039","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1359\/jbmr.090209","article-title":"Antifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fracture","volume":"24","author":"Eriksen","year":"2009","journal-title":"J Bone Miner Res."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.2283","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbmr.2283","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jbmr.2283","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/29\/12\/2545\/56564813\/jbmr2283.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/29\/12\/2545\/56564813\/jbmr2283.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:52:23Z","timestamp":1710341543000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/29\/12\/2545-2551\/7598815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,16]]},"references-count":39,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,5,16]]},"published-print":{"date-parts":[[2014,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.2283","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,12,1]]},"published":{"date-parts":[[2014,5,16]]}}}